Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Inclusion and diversity in clinical trials: Actionable steps to drive lasting change

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106740Source: DataRank Database

Inclusion and diversity in clinical trials: Actionable steps to drive lasting change is a research paper published in Contemporary Clinical Trials (2022). On theSindex it has a DataRank of 0.785. It has been cited 186 times.

N/A

0.785DataRank · unranked

Scored on demand from live citation data

Open Access186 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: greenTopics (14)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.785

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

Bray Patrick‐Lake,Raolat M. Abdulai,Uli C. Broedl ORCID,Adam Brown ORCID,Ellen G. Cohn ORCID

Live enrichment

PubMed:35364292 PMC:PMC9133187

National Institutes of Health

Grant: 5T32HL069749-18

Postdoctoral Training in Cardiovascular Clinical Research

NHLBI NIH HHS

Grant: T32 HL069749

NIMHD NIH HHS

Grant: R01 MD013493

Abbott Laboratories

Boston Scientific Corporation

Cytokinetics

American Regent

Bayer Fund

Medtronic

Roche

Amgen

Gilead Sciences

Respicardia

Sanofi

AstraZeneca

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9133187

publisherhttps://api.elsevier.com/content/article/PII:S1551714422000660?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1551714422000660?httpAccept=text/plain

https://doi.org/10.1016/j.cct.2022.106740

https://pubmed.ncbi.nlm.nih.gov/35364292

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansUnited States Food and Drug AdministrationResearch PersonnelUnited States

Keywords

DiversityinclusionClinical TrialsUnderrepresented PopulationsUnited States Food and Drug AdministrationHumansResearch PersonnelUnited States

Sustainable Development Goals

SDG 3: 3. Good health

Related Papers (10)

The design and methods of the OPTIMUM study: A multisite pragmatic randomized clinical trial of a telehealth group mindfulness program for persons with chronic low back pain

N/A

0.790DataRank · unranked

Contemporary Clinical Trials(2021)

co-citedsame journal

10.1016/j.cct.2021.106545

STRategies to Improve Pain and Enjoy life (STRIPE): Protocol for a pragmatic randomized trial of pain coping skills training and opioid medication taper guidance for patients on long-term opioid therapy

N/A

0.227DataRank · unranked

Contemporary Clinical Trials(2021)

co-citedsame journal

10.1016/j.cct.2021.106499

Natural language processing of symptoms documented in free-text narratives of electronic health records: a systematic review

N/A

0.906DataRank · unranked

Journal of the American Medical Informatics Association(2019)

co-cited

10.1093/jamia/ocy173

Discovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities

N/A

0.933DataRank · unranked

Nature Reviews Neurology(2020)

co-cited

10.1038/s41582-020-0362-2

Stakeholder Engagement in Pragmatic Clinical Trials: Emphasizing Relationships to Improve Pain Management Delivery and Outcomes

Pain Medicine(2020)

co-cited

10.1093/pm/pnaa333

Optimizing Retention in a Pragmatic Trial of Community‐Living Older Persons: The STRIDE Study

N/A

0.720DataRank · unranked

Journal of the American Geriatrics Society(2020)

co-cited

10.1111/jgs.16356

Designing Trials with Purpose: Pragmatic Clinical Trials of Nonpharmacological Approaches for Pain Management

Pain Medicine(2020)

co-cited

10.1093/pm/pnaa347

Pilot and feasibility studies for pragmatic trials have unique considerations and areas of uncertainty

Journal of Clinical Epidemiology(2021)

co-cited

10.1016/j.jclinepi.2021.06.029

Optimizing the Impact of Pragmatic Clinical Trials for Veteran and Military Populations: Lessons From the Pain Management Collaboratory

N/A

0.241DataRank · unranked

Military Medicine(2021)

co-cited

10.1093/milmed/usab458

Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials

N/A

0.557DataRank · unranked

Clinical Infectious Diseases(2022)

co-cited

10.1093/cid/ciac692